Nov 17, 2026 8:30 am EST Conexeu Sciences Announces Early-Stage Development of W.A.F.E.R.™ Sheet and W.A.F.E.R.™ Lattice, Fabricated Formats of Its Investigational CXU™ Platform
Nov 10, 2026 8:30 am EST Conexeu Sciences Launches Human Collagen Initiative for Regenerative Aesthetics as GLP-1 Drives Demand for Tissue Restoration
Oct 15, 2026 4:30 pm EDT Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors
Oct 6, 2026 8:30 am EDT Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission
Aug 18, 2026 8:30 am EDT Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
Aug 11, 2026 8:30 am EDT Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration
Jul 14, 2026 8:30 am EDT The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
Jul 7, 2026 9:00 am EDT A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill
Jun 25, 2026 8:30 am EDT Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform